Pharmacological cardioversion of atrial fibrillation—a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously
Authors : Rónaszéki A; Alings M; Egstrup K; Gaciong Z; Hranai M; Király C; Sereg M; Figatowski W; Bondarov P; Johansson S; Frison L; Edvardsson N;
Affiliations : Department of Cardiology, Péterfy Hospital, Budapest, Hungary. Tel: +46 31 776 1000; fax: +46 31 776 3737 Email: anders.r.berggren@astrazeneca.com
Journal : Eurpopace (2011)
Related Links: Pubmed | Publisher website
Pharmacological cardioversion of atrial fibrillation—a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously
Authors : Rónaszéki A; Alings M; Egstrup K; Gaciong Z; Hranai M; Király C; Sereg M; Figatowski W; Bondarov P; Johansson S; Frison L; Edvardsson N;
Affiliations : Department of Cardiology, Péterfy Hospital, Budapest, Hungary. Corresponding author. Tel: +46 31 776 1000; fax: +46 31 776 3737, Email: anders.r.berggren@astrazeneca.com
Journal : EP Europace (2011)
Related Links: Pubmed | Publisher website
Display Ads on JAFIB to reach Users world wide...
Suggest an Event to get good mileage from Users World wide...